Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0000939767-25-000113
Filing Date
2025-07-28
Accepted
2025-07-28 16:31:54
Documents
76
Period of Report
2025-07-04

Document Format Files

Seq Description Document Type Size
1 10-Q exel-20250704.htm   iXBRL 10-Q 1339280
2 EX-31.1 exel20250630exhibit31110-q.htm EX-31.1 9468
3 EX-31.2 exel20250630exhibit31210-q.htm EX-31.2 9448
4 EX-32.1 exel20250630exhibit32110-q.htm EX-32.1 7245
10 exel-20250704_g1.jpg GRAPHIC 55431
  Complete submission text file 0000939767-25-000113.txt   7230747

Data Files

Seq Description Document Type Size
5 XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT exel-20250704.xsd EX-101.SCH 49020
6 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE DOCUMENT exel-20250704_cal.xml EX-101.CAL 74501
7 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE DOCUMENT exel-20250704_def.xml EX-101.DEF 218595
8 XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT exel-20250704_lab.xml EX-101.LAB 586435
9 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT exel-20250704_pre.xml EX-101.PRE 406355
78 EXTRACTED XBRL INSTANCE DOCUMENT exel-20250704_htm.xml XML 1131692
Mailing Address 1851 HARBOR BAY PARKWAY ALAMEDA CA 94502
Business Address 1851 HARBOR BAY PARKWAY ALAMEDA CA 94502 6508377000
EXELIXIS, INC. (Filer) CIK: 0000939767 (see all company filings)

EIN.: 043257395 | State of Incorp.: DE | Fiscal Year End: 0102
Type: 10-Q | Act: 34 | File No.: 000-30235 | Film No.: 251156029
SIC: 2836 Biological Products, (No Diagnostic Substances)
(CF Office: 03 Life Sciences)